Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis
- PMID: 21356084
- PMCID: PMC3060152
- DOI: 10.1186/1471-2172-12-18
Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis
Abstract
Background: Toll-like receptor 4 (TLR4) is widely recognized as an essential element in the triggering of innate immunity, binding pathogen-associated molecules such as Lipopolysaccharide (LPS), and in initiating a cascade of pro-inflammatory events. Evidence for TLR4 expression in non-immune cells, including pancreatic β-cells, has been shown, but, the functional role of TLR4 in the physiology of human pancreatic β-cells is still to be clearly established. We investigated whether TLR4 is present in β-cells purified from freshly isolated human islets and confirmed the results using MIN6 mouse insulinoma cells, by analyzing the effects of TLR4 expression on cell viability and insulin homeostasis.
Results: CD11b positive macrophages were practically absent from isolated human islets obtained from non-diabetic brain-dead donors, and TLR4 mRNA and cell surface expression were restricted to β-cells. A significant loss of cell viability was observed in these β-cells indicating a possible relationship with TLR4 expression. Monitoring gene expression in β-cells exposed for 48h to the prototypical TLR4 ligand LPS showed a concentration-dependent increase in TLR4 and CD14 transcripts and decreased insulin content and secretion. TLR4-positive MIN6 cells were also LPS-responsive, increasing TLR4 and CD14 mRNA levels and decreasing cell viability and insulin content.
Conclusions: Taken together, our data indicate a novel function for TLR4 as a molecule capable of altering homeostasis of pancreatic β-cells.
© 2011 Garay-Malpartida et al; licensee BioMed Central Ltd.
Figures
Similar articles
-
TLR4 is required for the obesity-induced pancreatic beta cell dysfunction.Acta Biochim Biophys Sin (Shanghai). 2013 Dec;45(12):1030-8. doi: 10.1093/abbs/gmt092. Epub 2013 Aug 28. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23985305
-
Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells.Clin Exp Immunol. 2003 Aug;133(2):208-18. doi: 10.1046/j.1365-2249.2003.02211.x. Clin Exp Immunol. 2003. PMID: 12869026 Free PMC article.
-
Effects of lipopolysaccharides on TLR4 expression in INS-1 rat insulinoma cells.Cell Mol Biol (Noisy-le-grand). 2011 Jun 23;57 Suppl:OL1513-9. Cell Mol Biol (Noisy-le-grand). 2011. PMID: 21699766
-
Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-Like Receptor-4 and NF-κB signalling.PLoS One. 2012;7(4):e36200. doi: 10.1371/journal.pone.0036200. Epub 2012 Apr 27. PLoS One. 2012. PMID: 22558381 Free PMC article.
-
Porphyromonas gingivalis lipopolysaccharide upregulates insulin secretion from pancreatic β cell line MIN6.J Periodontol. 2014 Nov;85(11):1629-36. doi: 10.1902/jop.2014.140070. Epub 2014 Jun 12. J Periodontol. 2014. PMID: 24921432 Free PMC article.
Cited by
-
Triglycerides: A Sensitizer but Not a Trigger for Hypertriglyceridemic Acute Pancreatitis.Dig Dis Sci. 2024 Jun;69(6):2123-2131. doi: 10.1007/s10620-024-08412-x. Epub 2024 Apr 12. Dig Dis Sci. 2024. PMID: 38609542
-
Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.Front Endocrinol (Lausanne). 2023 Nov 23;14:1269139. doi: 10.3389/fendo.2023.1269139. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38075070 Free PMC article. Review.
-
Astragalus polysaccharide restores insulin secretion impaired by lipopolysaccharides through the protein kinase B /mammalian target of rapamycin/glucose transporter 2 pathway.BMC Complement Med Ther. 2023 Oct 10;23(1):358. doi: 10.1186/s12906-023-04188-1. BMC Complement Med Ther. 2023. PMID: 37817130 Free PMC article.
-
How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk.Front Endocrinol (Lausanne). 2023 Jul 26;14:1205219. doi: 10.3389/fendo.2023.1205219. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37564976 Free PMC article. Review.
-
BefA, a microbiota-secreted membrane disrupter, disseminates to the pancreas and increases β cell mass.Cell Metab. 2022 Nov 1;34(11):1779-1791.e9. doi: 10.1016/j.cmet.2022.09.001. Epub 2022 Oct 13. Cell Metab. 2022. PMID: 36240759 Free PMC article.
References
-
- Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355:1318–30. doi: 10.1056/NEJMoa061267. - DOI - PubMed
-
- O'Gorman D, Kin T, Murdoch T, Richer B, McGhee-Wilson D, Ryan EA, Shapiro JA, Lakey JR. The standardization of pancreatic donors for islet isolations. Transplantation. 2005;80:801–6. - PubMed
-
- Contreras JL, Eckstein C, Smyth CA, Sellers MT, Vilatoba M, Bilbao G, Rahemtulla FG, Young CJ, Thompson JA, Chaudry IH, Eckhoff DE. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes. 2003;52:2935–42. doi: 10.2337/diabetes.52.12.2935. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials